GSK Remains on Track for 2031 Sales Above GBP40 Billion
GSK says it remains on track to achieve sales of more than GBP40 billion in 2031.
Related stories
Gulf International Services Reports 9-Month Net Profit of 144.6 Million Riyals
M impact | EARNINGS | Oct 29, 2026, 01:31 PM UTC
Merck Says Keytruda Sales Rose 6% to $8.6 Billion in Q3
Keytruda generated nearly half of Merck’s worldwide sales in the third quarter. Merck attributed the drug’s growth to uptake in earlier-stage indications and its new Qlex form.
M impact | EARNINGS | Oct 29, 2026, 01:30 PM UTC
Merck Executive Expects Moderate Top-Line Growth in 2027
A Merck executive said on a conference call that the company expects moderate top-line growth in 2027.
M impact | EARNINGS | Oct 29, 2026, 01:30 PM UTC
Endovastec Nine-Month Revenue Rises 10.26% to RMB 1.12 Billion
M impact | EARNINGS | Oct 29, 2026, 01:25 PM UTC
Archean Chemical Industries Reports Sept-Quarter Net Profit of 320.6 Million Rupees
M impact | EARNINGS | Oct 29, 2026, 01:24 PM UTC
Merck tops third-quarter forecasts on strong Keytruda and Gardasil results
Merck exceeded forecasts for the third quarter, citing strong results from Keytruda and Gardasil.
M impact | EARNINGS | Oct 29, 2026, 01:24 PM UTC